Rovi Receives Acquisition Offers for CDMO Unit Worth €2B to €3B

- Rovi has received multiple buyout offers for its contract development and manufacturing organization (CDMO) unit, potentially worth €2 billion to €3 billion.
- The CDMO unit generated €409 million in revenue last year.
- Private equity firms are among the bidders for the unit.
- Biogen is also pursuing dealmaking, planning to spend up to $8 billion this year.